Overview
Immunoproliferative disorder is a disorder. There are currently 2 actively recruiting clinical trials.
Clinical Trials
Recent Trials
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Research Evidence
Peer-reviewed studies linked via MeSH term "Disorders, Immunoproliferative" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Quick Facts
- SNOMED CT
- 127071007
- UMLS CUI
- C0021070
- Fully Specified Name
- Immunoproliferative disorder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Clinical Trials
- 4
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.